Table 3 Logistic regression analyses for ischemic stroke

Age

1.046 (0.979–1.117)

0.186

Sex

5.935 (0.684–51.483)

0.106

BMI

1.099 (0.950–1.272)

0.205

0.816 (0.606–1.099)

0.180

Smoking

2.557 (0.454–14.391)

0.287

Hypertension

4.114 (0.739–22.890)

0.106

2.268 (0.152–33.848)

0.553

Hypercholesterolemia

7.152 (1.386–36.913)

0.019*

69.265(2.26-2121.62)

0.015*

Diabetes

33.429 (3.793-294.603)

0.002*

119.67(5.15-7746.41)

0.005*

Primary symptom (%)

 Infarction

1.587 (0.314–8.009)

0.576

 Non-infarction

Reference

-

Laboratory results

 WBC count, 10⁹/L

1.368 (1.090–1.718)

0.007*

 LY count, 10⁹/L

0.911 (0.283–2.938)

0.877

 PLT count, 10⁹/L

1.007 (0.998–1.017)

0.139

 Cr, µmol/L

1.027 (0.991–1.065)

0.146

 UA, µmol/L

0.999 (0.990–1.008)

0.787

 ALT, U/L

1.014 (0.989–1.039)

0.278

 HDL, mmol/L

0.175 (0.009–3.528)

0.255

1.232 (0.051–29.524)

0.897

 LDL, mmol/L

0.673 (0.234–1.931)

0.461

 TG, mmol/L

1.295 (0.681–2.461)

0.431

 TC, mmol/L

0.609 (0.260–1.428)

0.254

 GGT, mmol/L

0.996 (0.956–1.037)

0.832

0.921 (0.823–1.031)

0.153

 HCY, µmol/L

1.047 (0.968–1.132)

0.251

 ApoA, g/L

0.910 (0.044–18.830)

0.952

 ApoB, g/L

0.652 (0.016–26.758)

0.822

Suzuki stage, n (%)

 1–3

Reference

-

 4–6

1.368 (0.245–7.630)

0.721

Surgical option (%)

 Indirect bypass

Reference

-

Reference

-

 Direct bypass

0.585 (0.105–3.246)

0.539

0.065 (0.003–1.291)

0.073

NAFLD

6.820 (1.220–38.130)

0.029*

27.145 (2.031–362.81)

0.013*